BELOW SUPERNAV drop zone ⇩

Weight loss drugs driving health care costs: Survey

  • 125 employers covering 17.1 million people were surveyed
  • 67% of employers covered obesity medication
  • Inflation and employers taking the cost burden are factors in the growth
"Wegovy", "Ozempic" and "Mounjaro" are sold in the Achat pharmacy in Mitte

“Wegovy”, “Ozempic” and “Mounjaro” are sold in the Achat pharmacy in Mitte.

MAIN AREA TOP drop zone ⇩

Mortgage Calculator

This calculator helps you estimate your monthly mortgage payment. It adds up the loan payment (principal + interest), property tax, and insurance. The loan payment is spread out over the years of your loan term.

This is the total amount you're borrowing from the bank.
This is the yearly interest rate on your loan.
This is how long you'll take to repay the loan.
This is the yearly tax you pay on your property.
This is the yearly cost to insure your home.

Monthly Payment Breakdown

Principal and Interest: $

Property Tax: $

Homeowners Insurance: $

Total Estimated Monthly Payment: $

(NewsNation) — A survey from 125 employer members of Business Group of Health has revealed demand for GLP-1s, otherwise known as diabetes and weight loss drugs, could drive up health care costs.

According to the data, an 8% hike of health care costs is expected in 2025; the greatest increase in a decade. For context, 2024 costs were a 7.2 increase on 2023.

What’s more, cumulative growth for adult health care has risen 50% since 2017. Various factors are at play, including inflation, employers unwilling to bestow the cost upon employees and pharmacy costs.

But it is GLP-1 medications such as Ozempic and Wegovy, that are driving health care costs upward, according to the survey of 125 employers, which cover 17.1 million people.

Cancer and musculoskeletal-related treatment were the first and second most costly treatments, though cardiovascular conditions came in at third.

Seventy-nine percent of employers surveyed outlined there was greater interest in GLP-1 medication among its members. So much so, 96% said they were concerned about future implications surrounding costs.

“Companies are always trying to balance a strong benefits offering that meets the needs of their employees with affordability,” Jeff Williams, U.S. President and CEO of benefits administration company, Aptia, told NewsNation.

“In our analysis and data, we see employers who fully understand and are doing their best to meet the needs of their diverse workforce be the most successful in these situations.

“As costs rise, employers are challenged now more than ever to balance their bottom line against the needs of their current and future employees to be competitive. This trend will no doubt continue.”

With obesity medication gaining popularity, 67% of employers surveyed covered this under their respective health care plans, while 96% covered diabetes treatments.

Health

Copyright 2024 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed

MAIN AREA MIDDLE drop zone ⇩

Trending on NewsNation

MAIN AREA BOTTOM drop zone ⇩

tt

KC Chiefs parade shooting: 1 dead, 21 shot including 9 kids | Morning in America

Witness of Chiefs parade shooting describes suspect | Banfield

Kansas City Chiefs parade shooting: Mom of 2 dead, over 20 shot | Banfield

WWE star Ashley Massaro 'threatened' by board to keep quiet about alleged rape: Friend | Banfield

Friend of WWE star: Ashley Massaro 'spent hours' sobbing after alleged rape | Banfield

Partly Cloudy

la

61°F Partly Cloudy Feels like 61°
Wind
5 mph SW
Humidity
56%
Sunrise
Sunset

Tonight

Partly cloudy this evening, then becoming cloudy after midnight. Low 48F. Winds light and variable.
48°F Partly cloudy this evening, then becoming cloudy after midnight. Low 48F. Winds light and variable.
Wind
4 mph N
Precip
2%
Sunset
Moon Phase
Waning Crescent